The Protease Inhibitor Cystatin C Is Differentially Expressed among Dendritic Cell Populations, but Does Not Control Antigen Presentation

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 5003-5011

  El Sukkari, Dima ^a   Wilson, Nicholas S ^a,b   Hakansson, Katarina ^c   Steptoe, Raymond J ^a   Grubb, Anders ^c   Shortman, Ken ^a   Villadangos, José A ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b University of Melbourne   (Australia)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN S; CD8 ANTIGEN; CYSTATIN C; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEINASE INHIBITOR;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CELL MATURATION; CELL MEMBRANE; CELL TYPE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

EID: 0242495719     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.5003     Document Type: Article

References (49)

1. Villadangos, J. A. 2001. Presentation of antigens by MHC II molecules: getting the most out of them. Mol. Immunol. 38:329.
2. Villadangos, J. A., and H. L. Ploegh. 2000. Proteolysis in MHC II antigen presentation: who's in charge? Immunity 12:233.
3. Manoury, B., D. Mazzeo, D. N. Li, J. Billson, K. Loak, P. Benaroch, and C. Watts. 2003. Asparagine endopeptidase can initiate the removal of the MHC II invariant chain chaperone. Immunity 18:489.
4. Riese, R. J., P. R. Wolf, D. Bromme, L. R. Natkin, J. A. Villadangos, H. L. Ploegh, and H. A. Chapman. 1996. Essential role for cathepsin S in MHC II-associated invariant chain processing and peptide loading. Immunity 4:357.
5. Villadangos, J. A., R. J. Riese, C. Peters, H. A. Chapman, and H. L. Ploegh. 1997. Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 186:549.
6. Shi, G. P., J. A. Villadangos, G. Dranoff, C. Small, L. Gu, K. J. Haley, R. Riese, H. L. Ploegh, and H. A. Chapman. 1999. Cathepsin S required for normal MHC II peptide loading and germinal center development. Immunity 10:197.
7. Shi, G. P., R. A. Bryant, R. Riese, S. Verhelst, C. Driessen, Z. Li, D. Bromme, H. L. Ploegh, and H. A. Chapman. 2000. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191:1177.
8. Nakagawa, T., W. Roth, P. Wong, A. Nelson, A. Farr, J. Deussing, J. A. Villadangos, H. Ploegh, C. Peters, and A. Y. Rudensky. 1998. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280:450.
9. Nakagawa, T. Y., W. H. Brissette, P. D. Lira, R. J. Griffiths, N. Petrushova, J. Stock, J. D. McNeish, S. E. Eastman, E. D. Howard, S. R. Clarke, et al. 1999. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 10:207.
10. Beers, C., K. Honey, S. Fink, K. Forbush, and A. Rudensky. 2003. Differential regulation of cathepsin S and cathepsin L in interferon γ-treated macrophages. J. Exp. Med. 197:169.
11. Amigorena, S., P. Webster, J. Drake, J. Newcomb, P. Cresswell, and I. Mellman. 1995. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. Exp. Med. 181:1729.
12. Brachet, V., G. Raposo, S. Amigorena, and I. Mellman. 1997. Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J. Cell Biol. 137:51.
13. Driessen, C., R. A. Bryant, A. M. Lennon-Dumenil, J. A. Villadangos, P. W. Bryant, G. P. Shi, H. A. Chapman, and H. L. Ploegh. 1999. Cathepsin S controls the trafficking and maturation of MHC II molecules in dendritic cells. J. Cell Biol. 147:775.
14. Alfonso, C., and L. Karlsson. 2000. Nonclassical MHC II molecules. Annu. Rev. Immunol. 18:113.
15. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
16. Steinman, R. M., and M. C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99:351.
17. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621.
18. Schuler, G., N. Romani, and R. M. Steinman. 1985. A comparison of murine epidermal Langerhans cells with spleen dendritic cells. J. Invest. Dermatol. 85:99s.
19. Pierre, P., S. J. Turley, E. Gatti, M. Hull, J. Meltzer, A. Mirza, K. Inaba, R. M. Steinman, and I. Mellman. 1997. Developmental regulation of MHC II transport in mouse dendritic cells. Nature 388:787.
20. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC 11 complexes on dendritic cells. Nature 388:782.
21. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185:317.
22. Villadangos, J. A., M. Cardoso, R. J. Steptoe, D. van Berkel, J. Pooley, F. R. Carbone, and K. Shortman. 2001. MHC II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14:739.
23. Pierre, P., and I. Mellman. 1998. Developmental regulation of invariant chain proteolysis controls MHC II trafficking in mouse dendritic cells. Cell 93:1135.
24. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164:2978.
25. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151.
26. Wilson, N. S., D. El-Sukkari, G. T. Belz, C. M. Smith, R. J. Steptoe, W. R. Heath, K. Shortman, and J. A. Villadangos. 2003. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102:2187.
27. Huh, C. G., K. Hakansson, C. M. Nathanson, U. P. Thorgeirsson, N. Jonsson, A. Grubb, M. Abrahamson, and S. Karlsson. 1999. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol. Pathol. 52:332.
28. Manca, F., J. A. Clarke, A. Miller, E. E. Sercarz, and N. Shastri. 1984. A limited region within hen egg-white lysozyme serves as the focus for a diversity of T cell clones. J. Immunol. 133:2075.
29. Alfonso, C., J. O. Han, G. S. Williams, and L. Karlsson. 2001. The impact of H2-DM on humoral immune responses. J. Immunol. 167:6348.
30. Inaba, K., M. Witmer-Pack, M. Inaba, K. S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P. S. Linsley, S. Ikehara, et al. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849.
31. Pulendran, B., J. Lingappa, M. K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C. R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 159:2222.
32. Villadangos, J. A., C. Driessen, G. P. Shi, H. A. Chapman, and H. L. Ploegh. 2000. Early endosomal maturation of MHC II molecules independently of cysteine proteases and H-2DM. EMBO J. 19:882.
33. Germain, R. N., and L. R. Hendrix. 1991. MHC II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
34. Colledge, L., C. L. Bennett, P. A. Reay, and C. C. Blackburn. 2002. Rapid constitutive generation of a specific peptide-MHC II complex from intact exogenous protein in immature dendritic cells. Eur. J. Immunol. 32:3246.
35. Veeraswamy, R. K., M. Cella, M. Colonna, and E. R. Unanue. 2003. Dendritic cells process and present antigens across a range of maturation states. J. Immunol. 170:5367.
36. Inaba, K., S. Turley, T. Iyoda, F. Yamaide, S. Shimoyama, C. Reis e Sousa, R. N. Germain, I. Mellman, and R. M. Steinman. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:927.
37. Turley, S. J., K. Inaba, W. S. Garrett, M. Ebersold, J. Unternaehrer, R. M. Steinman, and I. Mellman. 2000. Transport of peptide-MHC II complexes in developing dendritic cells. Science 288:522.
38. Rovere, P., V. S. Zimmermann, F. Forquet, D. Demandolx, J. Trucy, P. Ricciardi-Castagnoli, and J. Davoust. 1998. Dendritic cell maturation and antigen presentation in the absence of invariant chain. Proc. Natl. Acad. Sci. USA 95:1067.
39. Rescigno, M., S. Citterio, C. Thery, M. Rittig, D. Medaglini, G. Pozzi, S. Amigorena, and P. Ricciardi-Castagnoli. 1998. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc. Natl. Acad. Sci. USA 95:5229.
40. Abrahamson, M., I. Olafsson, A. Palsdottir, M. Ulvsback, A. Lundwall, O. Jensson, and A. Grubb. 1990. Structure and expression of the human cystatin C gene. Biochem. J. 268:287.
41. Huh, C., J. W. Nagle, C. A. Kozak, M. Abrahamson, and S. Karlsson. 1995. Structural organization, expression and chromosomal mapping of the mouse cystatin-C-encoding gene (Cst3). Gene 152:221.
42. Henskens, Y. M., E. C. Veerman, and A. V. Nieuw Amerongen. 1996. Cystatins in health and disease. Biol. Chem. Hoppe-Seyler 377:71.
43. Shi, G. P., G. K. Sukhova, A. Grubb, A. Ducharme, L. H. Rhode, R. T. Lee, P. M. Ridker, P. Libby, and H. A. Chapman. 1999. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest. 104:1191.
44. Olafsson, I., and A. Grubb. 2000. Hereditary cystatin C amyloid angiopathy. Amyloid 7:70.
45. Yamada, M. 2000. Cerebral amyloid angiopathy: an overview. Neuropathology 20:8.
46. Vray, B., S. Hartmann, and J. Hoebeke. 2002. Immunomodulatory properties of cystatins. Cell Mol. Life Sci. 59:1503.
47. Taupin, P., J. Ray, W. H. Fischer, S. T. Suhr, K. Hakansson, A. Grubb, and F. H. Gage. 2000. FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron 28:385.
48. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC II peptide-loading pathway. Cell 84:531.
49. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84:543.